How Much Did Polpharma Raise?
Funding & Key Investors

Polpharma, a cornerstone of the Polish pharmaceutical sector, has successfully secured significant capital to bolster its operational capabilities. The firm has reached a cumulative capital milestone of $50.3M, underscored by a recent strategic investment of $50.3M. This infusion of liquidity marks a pivotal moment for the Starogard Gdański-based manufacturer as it seeks to optimize its production infrastructure and expand its footprint within the competitive European healthcare landscape.

What is Polpharma?

Polpharma
ManufacturingPharmaceuticals

Headquartered in Starogard Gdański, Polpharma operates as a premier pharmaceutical manufacturer, specializing in the development and production of high-quality medicinal products. The company maintains a robust market position by integrating advanced manufacturing processes with a deep commitment to therapeutic innovation. By focusing on both generic and specialized pharmaceutical solutions, Polpharma serves as a critical link in the regional supply chain, ensuring that essential healthcare products remain accessible while adhering to stringent international quality standards. Its operational model is characterized by a blend of traditional pharmaceutical expertise and modern industrial efficiency, positioning the firm as a leader in the Central and Eastern European life sciences sector.

How much funding has Polpharma raised?

Polpharma has raised a total of $50.3M across 1 funding round:

2015

Debt

$50.3M

Debt (2015): $50.3M with participation from European Investment Bank

Key Investors in Polpharma

European Investment Bank

The European Investment Bank Group focuses on investing in people and ideas to enhance education, social resilience, and partnerships, supporting projects that contribute to Europe's competitiveness and inclusive growth.

What's next for Polpharma?

With this major enterprise-level funding, Polpharma is well-positioned to accelerate its strategic growth initiatives. The capital is expected to facilitate the modernization of manufacturing facilities and the potential expansion of its research and development pipeline. As the company navigates the complexities of the global pharmaceutical market, this financial backing provides the necessary stability to pursue long-term sustainability goals and enhance its competitive edge. Future efforts will likely focus on scaling production capacity to meet rising demand and exploring new therapeutic areas that align with the company's core competencies in pharmaceutical manufacturing and distribution.

See full Polpharma company page
See More Financial Insights
No matching results.
Refine your search.

Additional financial insights in the Manufacturing industry

Industrial Machinery & EquipmentManufacturing
Industrial Machinery & EquipmentManufacturingAppliancesAutomotive Parts
Industrial Machinery & EquipmentManufacturingConsumer ServicesRepair Services
Hand, Power & Lawn-care ToolsManufacturingIndustrial Machinery & Equipment

Frequently Asked Questions Regarding Polpharma Financial Insights

What are the most recent funding rounds that Polpharma has completed, and what were the funding rounds?
Polpharma has recently completed 1 funding rounds: Debt on Jun 3, 2015.
What is the total amount of funding Polpharma has raised to date?
Polpharma has raised a total of $50.3M in funding to date.
How many funding rounds has Polpharma completed?
Polpharma has completed 1 funding rounds.
How much funding did Polpharma raise in its most recent funding round?
Polpharma raised $50.3M in its most recent funding round.
Who are the lead investors in Polpharma's latest funding round?
The lead investor in Polpharma's latest funding round was European Investment Bank. To access investor data and explore similar companies, sign up for ZoomInfo.
Which was the largest funding round in Polpharma's history?
The largest funding round in Polpharma's history was $50.3M.
See more information about Polpharma